Filing Details
- Accession Number:
- 0001801385-24-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-28 21:33:56
- Reporting Period:
- 2024-02-26
- Accepted Time:
- 2024-02-28 21:33:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711279 | Krystal Biotech Inc. | KRYS | Biological Products, (No Disgnostic Substances) (2836) | 821080209 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801385 | Kathryn Romano | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-26 | 5,000 | $52.26 | 17,556 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-26 | 5,000 | $135.00 | 12,556 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-26 | 3,087 | $52.26 | 15,643 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-26 | 3,087 | $140.00 | 12,556 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-26 | 1,533 | $157.00 | 11,023 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-02-27 | 1,913 | $52.26 | 12,936 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-26 | 5,000 | $0.00 | 5,000 | $52.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-26 | 3,087 | $0.00 | 3,087 | $52.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-27 | 1,913 | $0.00 | 1,913 | $52.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2030-01-30 | No | 4 | M | Direct | |
| 1,913 | 2030-01-30 | No | 4 | M | Direct | |
| 0 | 2030-01-30 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 5,000 shares with a limit price of $135.00 per share.
- The transaction was executed in multiple trades at the same sale price.
- The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 3,087 shares with a limit price of $140.00 per share.
- Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 4,900 shares of restricted stock on February 26, 2024.
- The closing price on February 26, 2024 of the Company's common stock on NASDAQ.
- The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and holding 1,913 shares with a prior closing price from $135.00 per share.
- 50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021.
Billionaire Hedge Funds
